Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C36H62O11 |
Molecular Weight | 670.8709 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 17 / 17 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C
InChI
InChIKey=GAOZTHIDHYLHMS-KEOBGNEYSA-N
InChI=1S/C36H62O11/c1-10-34(31-20(3)16-26(43-31)28-19(2)15-21(4)36(41,18-37)46-28)12-11-27(44-34)33(8)13-14-35(47-33)17-25(38)22(5)30(45-35)23(6)29(42-9)24(7)32(39)40/h19-31,37-38,41H,10-18H2,1-9H3,(H,39,40)/t19-,20-,21+,22+,23-,24-,25-,26+,27+,28-,29+,30-,31+,33-,34-,35+,36-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20709963
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20709963
Monensin is an antibiotic produced as a byproduct of fermentation by Streptomyces cinnamonensis and belongs to a family of drugs known as polyether antibiotics or ionophores. The drug was approved by FDA for the prevention of coccidiosis in turkeys, chickens, quail, cattle, goats, calves (Coban, Rumensin). The exact mechanism of monesin action is unknown, however there are several hypotesis, which includes the inhibition of K+ transport, the inhibition of the transport of carbohydrates across the host cell membrane, the interruption host cell invasion by sporozoites, etc.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20709963
Curator's Comment: # Eli Lilly and the Department of Biochemistry of Indiana University School of Medicine
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method. | 1999 Sep 15 |
|
In vitro activity of the polyether ionophorous antibiotic monensin against the cyst form of Toxoplasma gondii. | 2000 Oct |
|
HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset. | 2001 |
|
Synthesis of monensin derivatives and their effect on the activity of ricin A-chain immunotoxins. | 2001 |
|
Effect of ionophores on in vitro excystment of Paragonimus ohirai metacercariae. | 2001 Apr |
|
Effects of L-glutamate, D-aspartate, and monensin on glycolytic and oxidative glucose metabolism in mouse astrocyte cultures: further evidence that glutamate uptake is metabolically driven by oxidative metabolism. | 2001 Apr |
|
Engineering of complex polyketide biosynthesis--insights from sequencing of the monensin biosynthetic gene cluster. | 2001 Dec |
|
Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. | 2001 Dec |
|
Regulation of Ca(2+) signals in a parotid cell line Par-C5. | 2001 Dec |
|
Colocalization of beta 1,4galactosyltransferase with mannose 6-phosphate receptor in monensin-induced TGN-derived structures. | 2001 Feb |
|
Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. | 2001 Feb |
|
Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. | 2001 Jan 15 |
|
Matrix vesicles and media vesicles as nonclassical pathways for the secretion of m-Calpain from MC3T3-E1 cells. | 2001 Jul 20 |
|
Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. | 2001 Jun 1 |
|
Evaluation of monensin and brefeldin A for flow cytometric determination of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in monocytes. | 2001 Jun 15 |
|
Measurement of potency and lipids in monensin fermentation broth by near-infrared spectroscopy. | 2001 May |
|
Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma production. | 2001 May 1 |
|
Expression of P-glycoprotein in the chicken. | 2001 Sep |
|
Constitutive internalization of constitutively active agiotensin II AT(1A) receptor mutants is blocked by inverse agonists. | 2002 Feb 22 |
Patents
Sample Use Guides
Monensin is taken orally at a dose of 73 g/ton feed (quail), 54-90 g/ton feed (turkeys), 90-110 g/ton feed (chickens), 0.14-0.42 mg/pound body weight (cattle fed in confinement for slaughter, growing cattle, mature reproducing beef cows), 0.14-1 mg/pound body weight (calves), 20 g/ton feed (goats).
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6624194
Eimeria tenella (Coccidia, Sporozoa) was incubated in media containing 1 ppm, 10 ppm or 100 ppm of monesin and free merozoites were destroyed after 20 min. Dose of 125 ppm monensin was found to bring about an equivalent protective effect against an infection with 40,000 Eimeria tenella oocysts.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
||
|
CFR |
21 CFR 556.420
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
||
|
WHO-VATC |
QA16QA06
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
||
|
NCI_THESAURUS |
C258
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
||
|
WHO-VATC |
QP51AH03
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
||
|
CFR |
21 CFR 558.355
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
906O0YJ6ZP
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
D008985
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
MONENSIN
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
906O0YJ6ZP
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
1368208
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB11430
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
241-154-0
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
2501
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL256105
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
27617
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
DTXSID4048561
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
C83971
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
7031
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
100000080379
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
441145
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
SUB09048MIG
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | |||
|
m7602
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
17090-79-8
Created by
admin on Fri Dec 15 17:35:50 GMT 2023 , Edited by admin on Fri Dec 15 17:35:50 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)